SciTransfer
Organization

GRAPHEXT LABS SL

Spanish data analytics SME behind Graphext, a platform that makes data science accessible to non-technical business users.

Technology SMEdigitalESSMENo active H2020 projects
H2020 projects
2
As coordinator
2
Total EC funding
€1.8M
Unique partners
0
What they do

Their core work

Graphext Labs is a Spanish data analytics software company that builds a platform for making advanced data science accessible to business users without requiring deep technical expertise. Their core product — Graphext — is a visual analytics tool that transforms raw datasets into interactive, actionable business intelligence without hand-coding. The company secured EU funding to scale this product from a feasibility concept into a commercial platform capable of serving enterprise clients across multiple sectors. Their value proposition is reducing the gap between data scientists and business decision-makers by automating much of the analytical workflow.

Core expertise

What they specialise in

Advanced analytics platform developmentprimary
2 projects

Both H2020 projects (2018 feasibility and 2019-2022 full development) center on building and scaling the Graphext analytics platform.

Data science democratization and no-code analyticsprimary
2 projects

GRAPHEXT (2019-2022) explicitly targets bringing 'data-science insight to the masses', indicating a product design philosophy around accessibility over technical depth.

Business intelligence toolingsecondary
1 project

Business Intelligence is listed as a keyword in the 2019-2022 project, signaling a commercial BI market positioning alongside the data science angle.

Evolution & trajectory

How they've shifted over time

Early focus
Feasibility and market validation
Recent focus
Advanced analytics platform scale-up

In their 2018 SME Phase 1 feasibility project, Graphext Labs was still in concept-validation mode with no published technical keywords, suggesting the product was early-stage and the focus was on market sizing and technical proof-of-concept. By 2019, with a 35x increase in funding (EUR 50K to EUR 1.74M), the project had matured into a fully defined product around advanced analytics, data science, and business intelligence. The trajectory is a textbook SME Instrument path: validate fast, then scale commercially — their entire EU engagement was a funding ladder for a single product.

Their H2020 engagement was a deliberate two-step product launch strategy and they are likely now in post-EU-funding commercial growth mode, making them more relevant as a technology provider than a research collaborator.

Collaboration profile

How they like to work

Role: consortium_leaderReach: regional

Graphext Labs operated exclusively as a solo coordinator under the SME Instrument, which by design does not involve research consortia — companies apply alone and retain full IP. This means they have zero recorded consortium experience in H2020, not because they are isolated, but because the funding instrument they chose does not require partners. Anyone looking to collaborate with them should expect a vendor or technology-licensing relationship rather than a co-research dynamic.

Graphext Labs has no recorded H2020 consortium partners, which is entirely typical for SME Instrument recipients who apply and execute as single-entity projects. Their network, if any, would be commercial rather than research-based and is not visible in CORDIS data.

Why partner with them

What sets them apart

Graphext Labs is one of very few Spanish SMEs to successfully secure both phases of the SME Instrument for a data analytics product, demonstrating that their concept passed rigorous EU evaluation twice. Their product occupies a specific niche: not a generic BI dashboard tool, but a platform that automates the analytical reasoning layer — closer to automated data science than to Tableau or Power BI. For consortia needing a data visualization or analytics tooling partner with a validated commercial product, they represent a rare combination of research credibility and market-ready software.

Notable projects

Highlights from their portfolio

  • GRAPHEXT
    The 2019-2022 Phase 2 project received EUR 1.74M — among the largest single-company EIC/SME Instrument grants — confirming the commercial and technical maturity of the platform at the time of award.
  • Graphext
    The 2018 Phase 1 feasibility study marks the origin point of the product concept and demonstrates the company successfully navigated the competitive two-phase SME Instrument ladder.
Cross-sector capabilities
Manufacturing quality analytics and process intelligenceHealth data analysis and clinical BI reportingEnergy sector operational data monitoringPolicy and social science data visualization
Analysis note: Only 2 projects with brief title descriptions and no deliverables or report summaries available. Profile is reliable for product direction and funding trajectory but cannot assess technical depth, team size, or post-2022 commercial status. The absence of consortium partners reflects the SME Instrument structure, not organizational isolation.